Stifel Maintains Hold on Bio-Techne, Lowers Price Target to $60

Benzinga · 5d ago
Stifel analyst Daniel Arias maintains Bio-Techne (NASDAQ:TECH) with a Hold and lowers the price target from $75 to $60.